You are here

PSGL-1 and mTOR regulate translation of ROCK-1 and physiological functions of macrophages.

TitlePSGL-1 and mTOR regulate translation of ROCK-1 and physiological functions of macrophages.
Publication TypeJournal Article
Year of Publication2007
AuthorsFox, R, Nhan, TQ, G Law, L, Morris, DR, W Liles, C, Schwartz, SM
JournalEMBO J
Volume26
Issue2
Pagination505-15
Date Published2007 Jan 24
ISSN0261-4189
KeywordsAnimals, Cell Adhesion, Cells, Cultured, Gene Expression Regulation, Intracellular Signaling Peptides and Proteins, Macrophages, Peritoneal, Male, Membrane Glycoproteins, Mice, Mice, Inbred C57BL, Mice, Knockout, Models, Biological, Oncogene Protein v-akt, Protein Biosynthesis, Protein Kinases, Protein-Serine-Threonine Kinases, rho-Associated Kinases, TOR Serine-Threonine Kinases
Abstract

Rho-associated kinases (ROCKs) are critical molecules involved in the physiological functions of macrophages, such as chemotaxis and phagocytosis. We demonstrate that macrophage adherence promotes rapid changes in physiological functions that depend on translational upregulation of preformed ROCK-1 mRNA, but not ROCK-2 mRNA. Before adherence, both ROCK mRNAs were present in the cytoplasm of macrophages, whereas ROCK proteins were undetectable. Macrophage adherence promoted signaling through P-selectin glycoprotein ligand-1 (PSGL-1)/Akt/mTOR that resulted in synthesis of ROCK-1, but not ROCK-2. Following synthesis, ROCK-1 was catalytically active. In addition, there was a rapamycin/sirolimus-sensitive enhanced loading of ribosomes on preformed ROCK-1 mRNAs. Inhibition of mTOR by rapamycin abolished ROCK-1 synthesis in macrophages resulting in an inhibition of chemotaxis and phagocytosis. Macrophages from PSGL-1-deficient mice recapitulated pharmacological inhibitor studies. These results indicate that receptor-mediated regulation at the level of translation is a component of a rapid set of mechanisms required to direct the macrophage phenotype upon adherence and suggest a mechanism for the immunosuppressive and anti-inflammatory effects of rapamycin/sirolimus.

DOI10.1038/sj.emboj.7601522
Alternate JournalEMBO J.
PubMed ID17245434